Health CanadaGeneral Alert
Health Canada Confirms License Suspension of Biolyse Pharma for Serious Manufact...
Published: May 9, 2014Recall ID: 51217Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Health Canada Confirms License Suspension of Biolyse Pharma for Serious Manufacturing Concerns - Supply of paclitaxel will not be disrupted for Canadian patients
Additional Source Details
| Field | Value |
|---|---|
| N I D | 51217 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-confirms-license-suspension-biolyse-pharma-serious-manufacturing |
| Issue | Product safety |
| Title | Health Canada Confirms License Suspension of Biolyse Pharma for Serious Manufacturing Concerns - Supply of paclitaxel will not be disrupted for Canadian patients |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2014-05-09 |
| Organization | Communications and Public Affairs Branch |